177 related articles for article (PubMed ID: 35301086)
1. Abnormal mitochondria in Down syndrome iPSC-derived GABAergic interneurons and organoids.
Xu L; Huo HQ; Lu KQ; Tang XY; Hong Y; Han X; Fu ZX; Fang KH; Xu M; Guo X; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166388. PubMed ID: 35301086
[TBL] [Abstract][Full Text] [Related]
2. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.
Tang XY; Xu L; Wang J; Hong Y; Wang Y; Zhu Q; Wang D; Zhang XY; Liu CY; Fang KH; Han X; Wang S; Wang X; Xu M; Bhattacharyya A; Guo X; Lin M; Liu Y
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945512
[TBL] [Abstract][Full Text] [Related]
3. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.
Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P
Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512
[TBL] [Abstract][Full Text] [Related]
4. Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons.
Huo HQ; Qu ZY; Yuan F; Ma L; Yao L; Xu M; Hu Y; Ji J; Bhattacharyya A; Zhang SC; Liu Y
Stem Cell Reports; 2018 Apr; 10(4):1251-1266. PubMed ID: 29526735
[TBL] [Abstract][Full Text] [Related]
5. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
Çağlayan ES
Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mitochondrial and metabolic alterations induced by trisomy 21 during neural differentiation.
Prutton KM; Marentette JO; Maclean KN; Roede JR
Free Radic Biol Med; 2023 Feb; 196():11-21. PubMed ID: 36638900
[TBL] [Abstract][Full Text] [Related]
7. RUNX1 Upregulation Causes Mitochondrial Dysfunction via Regulating the PI3K-Akt Pathway in iPSC from Patients with Down Syndrome.
Liu Y; Zhang Y; Ren Z; Zeng F; Yan J
Mol Cells; 2023 Apr; 46(4):219-230. PubMed ID: 36625318
[TBL] [Abstract][Full Text] [Related]
8. Trisomy 21 results in modest impacts on mitochondrial function and central carbon metabolism.
Anderson CC; Marentette JO; Prutton KM; Rauniyar AK; Reisz JA; D'Alessandro A; Maclean KN; Saba LM; Roede JR
Free Radic Biol Med; 2021 Aug; 172():201-212. PubMed ID: 34129926
[TBL] [Abstract][Full Text] [Related]
9. DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models.
Liu H; Caballero-Florán RN; Hergenreder T; Yang T; Hull JM; Pan G; Li R; Veling MW; Isom LL; Kwan KY; Huang ZJ; Fuerst PG; Jenkins PM; Ye B
PLoS Biol; 2023 Apr; 21(4):e3002078. PubMed ID: 37079499
[TBL] [Abstract][Full Text] [Related]
10. Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome.
Teles E Silva AL; Yokota BY; Sertié AL; Zampieri BL
Stem Cell Rev Rep; 2023 May; 19(4):1116-1123. PubMed ID: 36652145
[TBL] [Abstract][Full Text] [Related]
11. A Novel LHX6 Reporter Cell Line for Tracking Human iPSC-Derived Cortical Interneurons.
Cruz-Santos M; Cardo LF; Li M
Cells; 2022 Mar; 11(5):. PubMed ID: 35269475
[TBL] [Abstract][Full Text] [Related]
12. Generation of two induced pluripotent stem cell lines from patients with Down syndrome.
Zhu W; Liu W; Yu R; Manning M; Waran Romfh A; Wu JC
Stem Cell Res; 2023 Oct; 72():103204. PubMed ID: 37734318
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed Down Syndrome Cell Adhesion Molecule (DSCAM) Deregulates P21-Activated Kinase (PAK) Activity in an In Vitro Neuronal Model of Down Syndrome: Consequences on Cell Process Formation and Extension.
Pérez-Núñez R; Barraza N; Gonzalez-Jamett A; Cárdenas AM; Barnier JV; Caviedes P
Neurotox Res; 2016 Jul; 30(1):76-87. PubMed ID: 26966010
[TBL] [Abstract][Full Text] [Related]
14. Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation.
Kim TG; Yao R; Monnell T; Cho JH; Vasudevan A; Koh A; Peeyush KT; Moon M; Datta D; Bolshakov VY; Kim KS; Chung S
Stem Cells; 2014 Jul; 32(7):1789-804. PubMed ID: 24648391
[TBL] [Abstract][Full Text] [Related]
15. Fusion of Regionally Specified hPSC-Derived Organoids Models Human Brain Development and Interneuron Migration.
Xiang Y; Tanaka Y; Patterson B; Kang YJ; Govindaiah G; Roselaar N; Cakir B; Kim KY; Lombroso AP; Hwang SM; Zhong M; Stanley EG; Elefanty AG; Naegele JR; Lee SH; Weissman SM; Park IH
Cell Stem Cell; 2017 Sep; 21(3):383-398.e7. PubMed ID: 28757360
[TBL] [Abstract][Full Text] [Related]
16. Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoids.
Brady MV; Mariani J; Koca Y; Szekely A; King RA; Bloch MH; Landeros-Weisenberger A; Leckman JF; Vaccarino FM
Mol Psychiatry; 2022 Dec; 27(12):5007-5019. PubMed ID: 36447010
[TBL] [Abstract][Full Text] [Related]
17. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.
Izzo A; Mollo N; Nitti M; Paladino S; Calì G; Genesio R; Bonfiglio F; Cicatiello R; Barbato M; Sarnataro V; Conti A; Nitsch L
Mol Med; 2018 Mar; 24(1):2. PubMed ID: 30134785
[TBL] [Abstract][Full Text] [Related]
19. Generation and Fusion of Human Cortical and Medial Ganglionic Eminence Brain Organoids.
Xiang Y; Yoshiaki T; Patterson B; Cakir B; Kim KY; Cho YS; Park IH
Curr Protoc Stem Cell Biol; 2018 Nov; 47(1):. PubMed ID: 30854156
[TBL] [Abstract][Full Text] [Related]
20. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
